Altunkaynak BZ, Onger ME, Turkmen AP, Yurt KK, Altun G, Yuce M (2016) Effects of Methylphenidate and Atomoxetine on Development of the Brain. In: Melatonin, Neuroprotective Agents and Antidepressant Therapy, edited by López-Muñoz F, Srinivasan V, de Berardis D, Álamo C, Kato AT, 825–845. Springer, New Delhi

Andreazza AC et al (2007) DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 31(6):1282–1288. https://doi.org/10.1016/j.pnpbp.2007.05.012

Article  CAS  PubMed  Google Scholar 

Carias E, Hamilton J, Robison LS, Delis F, Eiden R, Quattrin T, Hadjiargyrou M, Komatsu D, Thanos PK (2018) Chronic oral methylphenidate treatment increases microglial activation in rats. J Neural Transm (Vienna) 125(12):1867–1875. https://doi.org/10.1007/s00702-018-1931-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carreon-Trujillo S, Vazquez-Gonzalez D, Corona JC (2023) Atomoxetine decreases mitochondrial Biogenesis, fission and fusion in human Neuron-like cells but does not alter antioxidant defences. Cell Biochem Biophys 81(1):105–115. https://doi.org/10.1007/s12013-022-01116-x

Article  CAS  PubMed  Google Scholar 

Comim CM, Gomes KM, Reus GZ, Petronilho F, Ferreira GK, Streck EL, Dal-Pizzol F, Quevedo J (2014) Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder. Acta Neuropsychiatrica 26(2):96–103. https://doi.org/10.1017/neu.2013.35

Article  PubMed  Google Scholar 

Corona JC (2018) Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder. BioMed research international 2018: 4067597. https://doi.org/10.1155/2018/4067597

Corona JC (2020) Role of oxidative stress and neuroinflammation in Attention-Deficit/Hyperactivity disorder. Antioxid (Basel) 9(11). https://doi.org/10.3390/antiox9111039

Corona JC (2021) Pharmacological approaches for the treatment of Attention-deficit/hyperactivity disorder. In Attention-Deficit Hyperactivity Disorder: Diagnosis, Prevalence and Treatment, edited by Kyser, Brian M., 1–39. Nova Science Publishers, Inc. New York

Corona JC, Carreon-Trujillo S, Gonzalez-Perez R, Gomez-Bautista D, Vazquez-Gonzalez D, Salazar-Garcia M (2019) Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells. Sci Rep 9(1):13011. https://doi.org/10.1038/s41598-019-49609-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortese S (2020) Pharmacologic treatment of attention Deficit-Hyperactivity disorder. N Engl J Med 383(11):1050–1056. https://doi.org/10.1056/NEJMra1917069

Article  CAS  PubMed  Google Scholar 

Cui Q et al (2016) Blunted mGluR activation disinhibits striatopallidal transmission in parkinsonian mice. Cell Rep 17(9):2431–2444. https://doi.org/10.1016/j.celrep.2016.10.087

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cupertino RB et al (2020) Reduced fronto-striatal volume in attention-deficit/hyperactivity disorder in two cohorts across the lifespan. Neuroimage Clin 28:102403. https://doi.org/10.1016/j.nicl.2020.102403

Article  PubMed  PubMed Central  Google Scholar 

Davidson TL, Stevenson RJ (2024) Vulnerability of the hippocampus to insults: links to Blood-Brain barrier dysfunction. Int J Mol Sci 25(4). https://doi.org/10.3390/ijms25041991

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 69(12):e145–e157. https://doi.org/10.1016/j.biopsych.2011.02.036

Article  CAS  PubMed  Google Scholar 

Fumagalli F, Cattaneo A, Caffino L, Ibba M, Racagni G, Carboni E, Gennarelli M, Riva MA (2010) Sub-chronic exposure to Atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Research: Official J Italian Pharmacol Soc 62(6):523–529. https://doi.org/10.1016/j.phrs.2010.07.009

Article  CAS  Google Scholar 

Gold MS, Blum K, Oscar-Berman M, Braverman ER (2014) Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med 126(1):153–177. https://doi.org/10.3810/pgm.2014.01.2735

Article  PubMed  PubMed Central  Google Scholar 

Gomes KM, Petronilho FC, Mantovani M, Garbelotto T, Boeck CR, Dal-Pizzol F, Quevedo J (2008) Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats. Neurochem Res 33(6):1024–1027. https://doi.org/10.1007/s11064-007-9544-1

Article  CAS  PubMed  Google Scholar 

Goncalves J, Baptista S, Martins T, Milhazes N, Borges F, Ribeiro CF, Malva JO, Silva AP (2010) Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci 31(2):315–326. https://doi.org/10.1111/j.1460-9568.2009.07059.x

Article  PubMed  Google Scholar 

Gray JD et al (2007) Methylphenidate administration to juvenile rats alters brain areas involved in cognition, motivated behaviors, appetite, and stress. J Neurosci 27(27):7196–7207. https://doi.org/10.1523/JNEUROSCI.0109-07.2007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gur F, Cengiz M, Gur B (2021) Alternations in nuclear factor kappa beta activity (NF-kB) in the rat brain due to long-term use of Atomoxetine for treating ADHD: in vivo and in Silico studies. Biochem Biophys Res Commun 534:927–932. https://doi.org/10.1016/j.bbrc.2020.10.072

Article  CAS  PubMed  Google Scholar 

Hoogman M, Buitelaar JK, Faraone SV, Shaw P, Franke B, and group, E-Aw (2017) Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults - Authors’ reply. Lancet Psychiatry 4(6):440–441. https://doi.org/10.1016/S2215-0366(17)30200-6

Article  PubMed  Google Scholar 

Jang H, Boltz D, McClaren J, Pani AK, Smeyne M, Korff A, Webster R, Smeyne RJ (2012) Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J Neurosci 32(5):1545–1559. https://doi.org/10.1523/JNEUROSCI.5123-11.2012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kato TA, Yamauchi Y, Horikawa H, Monji A, Mizoguchi Y, Seki Y, Hayakawa K, Utsumi H, Kanba S (2013) Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry. Curr Med Chem 20(3):331–344. https://doi.org/10.2174/0929867311320030003

Article  CAS  PubMed  Google Scholar 

Lagace DC, Yee JK, Bolanos CA, Eisch AJ (2006) Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biol Psychiatry 60(10):1121–1130. https://doi.org/10.1016/j.biopsych.2006.04.009

Article  CAS  PubMed  Google Scholar 

Lempp T, Toennes SW, Wunder C, Russe OQ, Moser CV, Kynast KL, Freitag CM, Niederberger E (2013) Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug Atomoxetine. Prog Neuropsychopharmacol Biol Psychiatry 40:221–228. https://doi.org/10.1016/j.pnpbp.2012.08.012

Article  CAS  PubMed  Google Scholar 

Liddelow SA, Barres BA (2017) Reactive astrocytes: Production, Function, and therapeutic potential. Immunity 46(6):957–967. https://doi.org/10.1016/j.immuni.2017.06.006

Article  CAS  PubMed  Google Scholar 

Liddelow SA et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481–487. https://doi.org/10.1038/nature21029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martins MR, Reinke A, Petronilho FC, Gomes KM, Dal-Pizzol F, Quevedo J (2006) Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 1078(1):189–197. https://doi.org/10.1016/j.brainres.2006.01.004

Article  CAS  PubMed  Google Scholar 

Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, Atomoxetine ASG (2001) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108(5):E83. https://doi.org/10.1542/peds.108.5.e83

Article  CAS  PubMed  Google Scholar 

Motaghinejad M, Motevalian M, Shabab B (2016) Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Neurosci Lett 619:106–113. https://doi.org/10.1016/j.neulet.2015.12.015

Article  CAS  PubMed  Google Scholar 

Motaghinejad M, Motevalian M, Shabab B, Fatima S (2017) Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats. J Neural Transm (Vienna) 124(1):121–131. https://doi.org/10.1007/s00702-016-1623-5